Varicella infection and the impact of late entry into the Irish healthcare system.
We present a case which highlights several areas of concern relating to the prevention and management of varicella in Ireland. We review the pathophysiology of this virus and highlight its greater potential for morbidity in certain groups, most particularly adult males. The experience and opinions with regard to varicella vaccination in the US and other temperate countries is reviewed along with evidence of changing epidemiology of varicella infection. The National Immunisation Advisory Committee (NIAC) guidelines are reviewed in the context of our experience.
Feeney
Sinéad
S
Department of Infectious Diseases, St. James's Hospital, Dublin 8, Ireland. sineadfeeney2004@yahoo.com
Muldoon
Eavan
E
Barrett
Patrick
P
Martos
Ramon
R
Mulvihill
Niall
N
O'Flanagan
Darina
D
Bergin
Colm
C
D000082:Acetaminophen / Q000627:therapeutic use; D000212:Acyclovir / Q000627:therapeutic use; D000328:Adult; D058633:Antipyretics / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D053840:Brugada Syndrome / Q000150:complications; D002644:Chickenpox / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D019433:Chickenpox Vaccine / Q000008:administration & dosage; D054242:Emigrants and Immigrants / Q000706:statistics & numerical data; D014645:Herpesvirus 3, Human / Q000472:pathogenicity; D006801:Humans; D007494:Ireland / Q000453:epidemiology; D008297:Male; D013188:Sri Lanka / Q000208:ethnology; D017180:Tachycardia, Ventricular / Q000209:etiology; D014611:Vaccination / Q000592:standards
D058633:Antipyretics; D000998:Antiviral Agents; D019433:Chickenpox Vaccine; D000082:Acetaminophen; D000212:Acyclovir